---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-006473"
form_type: "8-K"
ticker: "BFLY"
cik: "0001804176"
company_name: "Butterfly Network, Inc."
filed_at: "2023-04-24T23:59:59+00:00"
generated_at: "2026-06-16T19:20:44.518478+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Joseph DeVivo appointed President, CEO, and Chairman of Butterfly Network, effective April 24, 2023

## Summary
- DeVivo replaces Jonathan Rothberg as CEO; Rothberg remains on board.
- Compensation: $875k base salary, 125% target bonus, $500k sign-on bonus (recoverable within 12 months).
- Equity grants: 2.4M time-based RSUs (vesting over 3 yrs), 1.6M performance RSUs tied to stock price targets of $3, $4.50, $6.
- DeVivo previously President at Teladoc Health, CEO of InTouch Health (sold to Teladoc for $1.1B), and Executive Chairman of Caption Health (sold to GE Healthcare).

## SEC filing metadata
- accession: 0001558370-23-006473
- form_type: 8-K
- ticker: BFLY
- cik: 0001804176
- company_name: Butterfly Network, Inc.
- filed_at: 2023-04-24T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1804176/000155837023006473/0001558370-23-006473-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1804176/000155837023006473/bfly-20230424x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-006473
- JSON: https://secwatch.observer/filing/0001558370-23-006473.json
- Plain text: https://secwatch.observer/filing/0001558370-23-006473.txt

## Key facts
- Executive change
  Joseph DeVivo was appointed as President and Chief Executive Officer, principal executive officer, and Chairman of the Board at Butterfly Network, Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer, principal executive officer, and Chairman of the Board
  source text: the Board approved the appointment of Joseph DeVivo as President and Chief Executive Officer, principal executive officer, and Chairman of the Board, effective as of April 24, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1804176/000155837023006473/0001558370-23-006473-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.